People · Operator
Named in public records as an officer, director or promoter · active 2010–2024 · Biotechnology, Pharmaceuticals, Biotech / Pharma, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| i2O Therapeutics, Inc. | — | Biotechnology | Series B | $43.9M | $34.9M | 2020 |
| Cage Bio, Inc. | — | Pharmaceuticals | Series A | $28.8M | $62.2M | 2019 |
| Fount Bio, Inc. | — | Biotech / Pharma | Series A | $8.2M | $171.5M | 2021 |
| DX Biosciences, Inc. | — | Other | Pre-Seed | $829K | $12.2M | 2010 |
Samir Mitragotri at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Samir Mitragotri on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Anthony Aiudi | 2 | 4 |
| Ravi Srinivasan | 2 | 3 |
| Robert Langer | 1 | 36 |
| Frank Foster | 1 | 12 |
| Dan Watkins | 1 | 8 |
| Kurt Graves | 1 | 5 |
| Russell Lebovitz | 1 | 3 |
| Katie Ellias | 1 | 3 |
| Jeff Keyser | 1 | 3 |
| Daniel Haimovic | 1 | 2 |
| Justin Burns | 1 | 2 |
| MyPhuong Lam | 1 | 1 |
| Nitin Joshi | 1 | 1 |
| Christopher Gagliardi | 1 | 1 |
| Mitragotri Mitragotri | 1 | 1 |
| Douglas Levinson | 1 | 1 |
| Sallie Cassel | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.